AZZA Salamony

Prof. AZZA Salamony

Egypt Center for Research and Regenerative Medicine, Cairo, Al Qāhirah, Egypt

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
WRWael Roshdy
Wael Roshdy
Ahmed KandeilAhmed Kandeil
Ahmed Kandeil
Rabeh El-SheshenyRabeh El-Shesheny
Rabeh El-Shesheny
MKMohamed K. Khalifa
Mohamed K. Khalifa
Ahmed A. Al-KarmalawyAhmed A. Al-Karmalawy
Ahmed A. Al-Karmalawy
AKAmr Kandeel
Amr Kandeel
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first detected in Egypt in February 2020. Data about the prevalence rates of the SARS-CoV-2 lineages are relatively scarce. To understand the genetic characteristics of SARS-CoV-2 in Egypt during several waves of the pandemic, we analyzed sequences of 1256 Egyptian SARS-CoV-2 full genomes from March 2020 to May 2021. From one wave to the next, dominant strains have been observed to be replaced by other dominant strains. We detected an emerging lineage of SARS-CoV-2 in Egypt that shares mutations with the variant of concern (VOC). The neutralizing capacity of sera collected from cases infected with C.36.3 against dominant strains detected in Egypt showed a higher cross reactivity of sera with C.36.3 compared to other strains. Using in silico tools, mutations in the spike of SARS-CoV-2 induced a difference in binding affinity to the viral receptor. The C.36 lineage is the most dominant SARS-CoV-2 lineage in Egypt, and the heterotrophic antigenicity of SARS-CoV-2 variants is asymmetric. These results highlight the value of genetic and antigenic analyses of circulating strains in regions where published sequences are limited.

4 March 2021 in Microbes and Infectious Diseases
Verified
Journal Article
Open access
PDF file
Yara ShamikhYara Shamikh
Yara Shamikh
ASAZZA Salamony
AZZA Salamony
KAKhaled Amer
Khaled Amer
MEMostafa Elnakib
Mostafa Elnakib
WHWael Hassan
Wael Hassan
MAMaha Abdelsalam
Maha Abdelsalam
Background: Blood groups' antigens, represent polymorphic traits inherited among populations, their expression differences, can increase or decrease the host susceptibility to infections. We aimed here to correlate the relation between the different blood groups and hosts' susceptibility towards COVID-19 infection.Methods: 355 samples, were analyzed for SARS-CoV-2 and blood groups typing. The candidates were then divided according to their results into; 210 positive-PCR (viral persistent, clearance and ICU admitted), and 145 negative-PCR contacts and then this results were compared. Results: The highest frequency in control and viral clearance group was O-phenotype, followed by A-phenotype and the least was AB-phenotype. The highest frequency in the viral persistent group, was A-group, showed followed by B-group and the least was O-group. Lastly in ICU group, A-group was the highest frequency, followed by O-group and the least was B-group. Using Chi-square method, a statistically significant result was observed (p-value= 0.034).Conclusions: The blood group-O was the protective phenotype, controversy to the O-group, A-group was the risky phenotype, also AB-group was risky, as it showed the lowest frequency in both control and viral clearance group. Interestingly, the B-group was the least group susceptible to have bad prognosis and be admitted to the ICU. This can be a safety guideline for classifying healthcare workers, according to their ABO, to work with suspected cases with COVID-19 and also may help in developing specific anti- histo-blood group antibodies as an effective co-therapy for COVID-19.

7 February 2025 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
ASAZZA Salamony
AZZA Salamony
MAMaha Abdelsalam
Maha Abdelsalam
NENancy ElGuindy
Nancy ElGuindy
WRWael Roshdy
Wael Roshdy
AYAmr Youssef
Amr Youssef
Yara ShamikhYara Shamikh
Yara Shamikh

21 June 2023 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Open access
PDF file
ASAZZA Salamony
AZZA Salamony
Yara ShamikhYara Shamikh
Yara Shamikh
KAKhaled Amer
Khaled Amer
TETarek Elnagdy
Tarek Elnagdy
MEMostafa Elnakib
Mostafa Elnakib
MAMaha Abdelsalam
Maha Abdelsalam
Many factors have been implicated in the pathogenesis and severity of COVID-19 pandemic. A wide variation in the susceptibility for SARS-CoV-2 infection among different population, gender and age has been observed. Multiple studies investigated the relationship between the antibody’s titre of previously vaccinated individuals and the susceptibility of coronavirus infection, to find a rapid effective therapy for this pandemic. This study focused on the association between measles-mumps-rubella (MMR) antibodies titre and the severity of COVID-19 infection. We aimed to investigate the correlation between the antibody’s titre of MMR and the SARS-CoV-2 infection susceptibility and disease severity, in a cohort of COVID-19 Egyptian patients, compared to a control group. MMR antibody titre was measured using enzyme Linked Immune Sorbent Assay; (ELISA) for 136 COVID-19 patients and 44 healthy individuals, as control group. There were high levels of measles and mumps antibodies titer in the deteriorating cases, which could not protect from SARS-CoV-2 infection. However, the rubella antibodies might protect from SARS-CoV-2 infection, but once the infection occurs, it may aggravate the risk of case deterioration. MMR antibodies could be used as a guideline for COVID-19 symptom-severity and, in turn, may be considered as an economic prognostic marker used for early protection from multiple autoimmune organ failure.